HIV Patients' kidney transplants: new study tracks rejection risk
NCT ID NCT01453192
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 27 HIV-positive people with kidney failure who received a kidney transplant. All were on a three-drug HIV treatment including Raltegravir. The goal was to see how many had graft rejection within 6 months, using blood tests and kidney biopsies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RENAL INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU Lille, Service de néphrologie
Lille, 59037, France
-
CHU De Caen, Service de Néphrologie Hémodialyse
Caen, 14033, France
-
CHU de Nantes, Service de Néphrologie et Immunologie Clinique
Nantes, 44093, France
-
Hopital Saint Louis, Service de Néphrologie
Paris, 75010, France
-
Hôpital Bretonneau, Service de Néphrologie
Tours, 37044, France
-
Hôpital Foch, Service de Néphrologie Transplantation
Suresnes, 92151, France
-
Hôpital Henri Mondor, Service de Néphrologie Transplantation
Créteil, 94010, France
-
Hôpital Kremlin Bicêtre, Service de Néphrologie
Le Kremlin-Bicêtre, 94275, France
-
Hôpital Necker, Service de Néphrologie adulte
Paris, 75743, France
-
Hôpital Pasteur, Service de Néphrologie - Transplantation
Nice, 06002, France
-
Hôpital Pellegrin, Service de Nephrologie, Transplantation Rénale, Dialyse
Bordeaux, 33076, France
-
Hôpital Rangueil, Service de Néphrologie, HTA, Dialyse, Transplantation
Toulouse, 31059, France
-
Hôpital TENON, Urgences Néphrologiques et Transplantation Rénale
Paris, 75970, France
-
Hôpital civil, Service de Néphrologie et Transplantation
Strasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single HIV pill tame the epidemic in africa?
- Could a shorter drug course beat a longer one for a deadly fungal infection?
- A kinder, more personal touch may help people with HIV stay in care — a large trial in zambia puts it to the test
- Can tracking HIV's genetic fingerprints reveal where the epidemic is heading?
- Can a new drug, GS-0415, help keep HIV in check? a First-in-Human trial aims to find out
- Could a shot replace daily HIV pills? new trial tests injectable combo